Literature DB >> 6609715

Successful treatment of exogenous aspergillus endophthalmitis: a case report.

P C Ho, F I Tolentino, A S Baker.   

Abstract

We describe the first case of successfully treated exogenous aspergillus endophthalmitis following penetrating injury and primary scleral wound repair. After repeated vitreous surgery with multiple intravitreous instillations of amphotericin B combined with intravenous antifungal therapy the patient's visual acuity was 6/18. A vigorous approach in the management of mycotic endophthalmitis is emphasised and the role of closed vitrectomy discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609715      PMCID: PMC1040365          DOI: 10.1136/bjo.68.6.412

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Candida endophthalmitis: report of an unusual case with isolation of the etiologic agent by vitreous biopsy.

Authors:  R D Stone; A R Irvine; G R O'Connor
Journal:  Ann Ophthalmol       Date:  1975-06

2.  OCULAR PENETRATION OF AMPHOTERICIN B: A REPORT OF LABORATORY STUDIES AND A CASE REPORT OF POSTSURGICAL CEPHALOSPORIUM ENDOPHTHALMITIS.

Authors:  W R GREEN; J E BENNETT; R D GOOS
Journal:  Arch Ophthalmol       Date:  1965-06

3.  Intravitreal amphotericin B toxicity.

Authors:  E N Souri; W R Green
Journal:  Am J Ophthalmol       Date:  1974-07       Impact factor: 5.258

4.  Toxicity of intravitreal injection of amphotericin B.

Authors:  A J Axelrod; G A Peyman; D J Apple
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

5.  Endogenous Aspergillus endophthalmitis occurring after kidney transplant.

Authors:  M A Naidoff; W R Green
Journal:  Am J Ophthalmol       Date:  1975-03       Impact factor: 5.258

6.  Intravitreal amphotericin B treatment of Candida endophthamitis.

Authors:  G A Stern; C L Fetkenhour; R B O'Grady
Journal:  Arch Ophthalmol       Date:  1977-01

7.  Aspergillus endophthalmitis in a drug abuser.

Authors:  J B Michelson; S D Freedman; D G Boyden
Journal:  Ann Ophthalmol       Date:  1982-11

8.  Aspergillosis in chronic granulomatous disease: therapeutic considerations.

Authors:  M L Corrado; D Cleri; S M Fikrig; J C Phillips; V I Ahonkhai
Journal:  Am J Dis Child       Date:  1980-11

9.  Pars plana vitrectomy in the management of endogenous Candida endophthalmitis.

Authors:  R C Snip; R G Michels
Journal:  Am J Ophthalmol       Date:  1976-11       Impact factor: 5.258

10.  Endogenous Aspergillus endophthalmitis in drug abusers.

Authors:  B H Doft; J G Clarkson; G Rebell; R K Forster
Journal:  Arch Ophthalmol       Date:  1980-05
View more
  6 in total

1.  A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating keratoplasty.

Authors:  N K Ragge; J C Hart; D L Easty; A G Tyers
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

2.  Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes.

Authors:  J Baldinger; B H Doft; S A Burns; B Johnson
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

3.  Retinal and choroidal infarction from Aspergillus: clinical diagnosis and clinicopathologic correlations.

Authors:  L M Jampol; S Dyckman; V Maniates; M Tso; M Daily; R O'Grady
Journal:  Trans Am Ophthalmol Soc       Date:  1988

4.  Scytalidium dimidiatum fungal endophthalmitis.

Authors:  A A al-Rajhi; A H Awad; S S al-Hedaithy; R K Forster; K C Caldwell
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

5.  Aspergillus terreus postoperative endophthalmitis.

Authors:  T Das; P Vyas; S Sharma
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

6.  Novel diagnosis of fungal endophthalmitis by broad-range real-time PCR detection of fungal 28S ribosomal DNA.

Authors:  Manabu Ogawa; Sunao Sugita; Ken Watanabe; Norio Shimizu; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-15       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.